A Trial of Cognitive Behavioral Therapy in Familial Dysautonomia
| Status: | Completed |
|---|---|
| Conditions: | Anxiety, Neurology |
| Therapuetic Areas: | Neurology, Psychiatry / Psychology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/31/2019 |
| Start Date: | December 6, 2016 |
| End Date: | July 20, 2018 |
An Open-Label Pilot Trial of Cognitive Behavioral Therapy in Familial Dysautonomia
To determine the effect of cognitive behavioral therapy (CBT) in the severity of anxiety and
depression in adult patients with familial dysautonomia. Patients will be enrolled in an
8-week CBT program. All CBT sessions will be done either in person at the NYU Dysautonomia
Center or over the phone to help accommodate disability and potential physical limitations of
our patient population.
depression in adult patients with familial dysautonomia. Patients will be enrolled in an
8-week CBT program. All CBT sessions will be done either in person at the NYU Dysautonomia
Center or over the phone to help accommodate disability and potential physical limitations of
our patient population.
Cognitive behavioral therapy (CBT), defined as a program of interventions that utilize
education to teach relaxation, healthy coping skills, stress management, assertiveness
training in order to help the individual identify and correct maladaptive beliefs in
combination with education to help practice symptom reduction and improve quality of life and
function. Patients will participate in eight forty-five minute sessions of CBT with a mental
health therapist in order to help treat generalized anxiety disorder, anxiety disorder due to
another medical condition (familial dysautonomia), major depressive disorder, persistent
depressive disorder (dysthymia), substance/medication- induced depressive disorder,
depressive disorder due to another medical condition.
education to teach relaxation, healthy coping skills, stress management, assertiveness
training in order to help the individual identify and correct maladaptive beliefs in
combination with education to help practice symptom reduction and improve quality of life and
function. Patients will participate in eight forty-five minute sessions of CBT with a mental
health therapist in order to help treat generalized anxiety disorder, anxiety disorder due to
another medical condition (familial dysautonomia), major depressive disorder, persistent
depressive disorder (dysthymia), substance/medication- induced depressive disorder,
depressive disorder due to another medical condition.
Inclusion Criteria:
- Diagnosis of FD (genetically confirmed)
- DSM-V criteria of major depressive disorder OR anxiety disorder
- STAI score ≥ 25 OR a PHQ-9 depression scale score ≥ 5 or greater
- Willing and able to complete 8 CBT sessions
- Maintain constant psychoactive medication through out study and no concurrent talk
therapy from another therapist.
Exclusion Criteria:
- Currently suicidal or having current suicidal ideations
- Currently under psychiatric treatment for depression or anxiety
- Have started any psychoactive medication within 3 months prior to screening
We found this trial at
1
site
550 1st Ave
New York, New York 10016
New York, New York 10016
(212) 263-7300
Principal Investigator: Horacio Kaufmann, MD
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
